Tenet Healthcare Corporation (NYSE:THC) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• Analyst consensus: Tenet has an average rating of "Moderate Buy" from 22 analysts (18 buy, 3 hold, 1 strong buy) with an average 1‑year price target of $250.56.
• Quarterly beat and guidance: Tenet reported Q EPS of $4.70 vs. $4.08 expected and revenue of $5.53B vs. $5.47B, and set FY2026 guidance of 16.190–18.470 EPS.
• Insider selling: Insiders sold 46,517 shares (~$10.94M) in the past 90 days, including an EVP sale of 24,000 shares, leaving insiders with 0.81% ownership.

Tenet Healthcare Corporation (NYSE:THC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-two analysts that are currently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $250.5556.

A number of brokerages have recently weighed in on THC. UBS Group upped their price target on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a "buy" rating in a report on Thursday, February 12th. Mizuho lifted their price objective on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an "outperform" rating in a research note on Thursday, March 12th. TD Cowen restated a "buy" rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Guggenheim lifted their price target on Tenet Healthcare from $271.00 to $283.00 and gave the company a "buy" rating in a research note on Thursday, March 12th. Finally, Wells Fargo & Company reissued an "overweight" rating and set a $265.00 price target on shares of Tenet Healthcare in a report on Monday, February 16th.

Tenet Healthcare Stock Performance

NYSE:THC opened at $205.28 on Friday. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. Tenet Healthcare has a fifty-two week low of $109.82 and a fifty-two week high of $247.21. The company has a market cap of $17.85 billion, a price-to-earnings ratio of 13.25, a PEG ratio of 0.98 and a beta of 1.39. The stock has a fifty day moving average price of $213.84 and a 200-day moving average price of $204.74.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts' consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare's revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities analysts anticipate that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Insider Transactions at Tenet Healthcare

In other news, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the sale, the executive vice president directly owned 8,012 shares in the company, valued at $1,875,128.48. This trade represents a 74.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 46,517 shares of company stock valued at $10,943,111. 0.81% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds have recently modified their holdings of THC. Triumph Capital Management bought a new position in Tenet Healthcare in the third quarter valued at about $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the fourth quarter worth about $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare in the fourth quarter valued at approximately $29,000. William B. Walkup & Associates Inc. bought a new position in Tenet Healthcare in the 3rd quarter valued at approximately $32,000. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare during the 2nd quarter worth approximately $35,000. Institutional investors and hedge funds own 95.44% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.